FMC - Nalco Home Program is a medicare approved dialysis facility center in Lexington, Kentucky and it has 3 dialysis stations. It is located in Fayette county at 1591 Winchester Rd., Ste 102, Lexington, KY, 40505. You can reach out to the office of FMC - Nalco Home Program at (859) 299-3379. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC - Nalco Home Program has the following ownership type - Profit. It was first certified by medicare in August, 2004. The medicare id for this facility is 182569 and it accepts patients under medicare ESRD program.
| Name | FMC - Nalco Home Program |
|---|---|
| Location | 1591 Winchester Rd., Ste 102, Lexington, Kentucky |
| No. of Dialysis Stations | 3 |
| Medicare ID | 182569 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 1591 Winchester Rd., Ste 102, Lexington, Kentucky, 40505 | |
| (859) 299-3379 | |
| Not Available |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 98 percent of surveyed rheumatologists indicate they will prescribe Roche's Actemra, an interleukin-6 inhibitor, for the treatment of rheumatoid arthritis following the agent's expected launch in 2010.
Previous studies have indicated that the heparanase (HPA) is correlated with histopathological parameters and poor prognosis of gastric cancers. Although their efficiencies in inhibiting the expression of HPA, the traditional HPA inhibitors may produce nonspecific and undesirable effects. In recent years, genetic approaches targeting HPA have been regarded as a promising alternative.
Compared with adult cancer patients, parents of children with cancer were more likely to be dissatisfied with the informed consent process for participating in clinical trials, according to a study from Dana-Farber/Children's Hospital Cancer Center. The findings will be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Saturday, Oct. 23.
Personal myths, aversive racism, heat and retaliation in baseball, and the power of writing about personal trauma - these are just a few of the research areas of the winners of the 2012 annual awards from the Society for Personality and Social Psychology (SPSP). Each of the recipients has made a unique and significant contribution to understanding the individual and social factors shaping people's personalities, interactions, and behaviors.
Cell Therapeutics, Inc. today announced that it has entered into exchange agreements with certain holders of some of the Company's outstanding 4% Convertible Senior Subordinated Notes due 2010.
› Verified 1 days ago
| NPI Number | 1235237413 |
| Doing Business As | Nalco, Llc |
| Address | 1591 Winchester Rd Lexington, Kentucky, 40505 |
| Phone Number | (859) 299-3379 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 98 percent of surveyed rheumatologists indicate they will prescribe Roche's Actemra, an interleukin-6 inhibitor, for the treatment of rheumatoid arthritis following the agent's expected launch in 2010.
Previous studies have indicated that the heparanase (HPA) is correlated with histopathological parameters and poor prognosis of gastric cancers. Although their efficiencies in inhibiting the expression of HPA, the traditional HPA inhibitors may produce nonspecific and undesirable effects. In recent years, genetic approaches targeting HPA have been regarded as a promising alternative.
Compared with adult cancer patients, parents of children with cancer were more likely to be dissatisfied with the informed consent process for participating in clinical trials, according to a study from Dana-Farber/Children's Hospital Cancer Center. The findings will be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Saturday, Oct. 23.
Personal myths, aversive racism, heat and retaliation in baseball, and the power of writing about personal trauma - these are just a few of the research areas of the winners of the 2012 annual awards from the Society for Personality and Social Psychology (SPSP). Each of the recipients has made a unique and significant contribution to understanding the individual and social factors shaping people's personalities, interactions, and behaviors.
Cell Therapeutics, Inc. today announced that it has entered into exchange agreements with certain holders of some of the Company's outstanding 4% Convertible Senior Subordinated Notes due 2010.
› Verified 1 days ago
| NPI Number | 1881925790 |
| Organization Name | Fresenius Medical Care Nalco Home Program |
| Doing Business As | Bio-medical Applications Of Kentucky, Inc. |
| Address | 1591 Winchester Rd Lexington, Kentucky, 40505 |
| Phone Number | (859) 299-3379 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 98 percent of surveyed rheumatologists indicate they will prescribe Roche's Actemra, an interleukin-6 inhibitor, for the treatment of rheumatoid arthritis following the agent's expected launch in 2010.
Previous studies have indicated that the heparanase (HPA) is correlated with histopathological parameters and poor prognosis of gastric cancers. Although their efficiencies in inhibiting the expression of HPA, the traditional HPA inhibitors may produce nonspecific and undesirable effects. In recent years, genetic approaches targeting HPA have been regarded as a promising alternative.
Compared with adult cancer patients, parents of children with cancer were more likely to be dissatisfied with the informed consent process for participating in clinical trials, according to a study from Dana-Farber/Children's Hospital Cancer Center. The findings will be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Saturday, Oct. 23.
Personal myths, aversive racism, heat and retaliation in baseball, and the power of writing about personal trauma - these are just a few of the research areas of the winners of the 2012 annual awards from the Society for Personality and Social Psychology (SPSP). Each of the recipients has made a unique and significant contribution to understanding the individual and social factors shaping people's personalities, interactions, and behaviors.
Cell Therapeutics, Inc. today announced that it has entered into exchange agreements with certain holders of some of the Company's outstanding 4% Convertible Senior Subordinated Notes due 2010.
› Verified 1 days ago
| Dialysis patients with Hemoglobin data | 7 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 98 percent of surveyed rheumatologists indicate they will prescribe Roche's Actemra, an interleukin-6 inhibitor, for the treatment of rheumatoid arthritis following the agent's expected launch in 2010.
Previous studies have indicated that the heparanase (HPA) is correlated with histopathological parameters and poor prognosis of gastric cancers. Although their efficiencies in inhibiting the expression of HPA, the traditional HPA inhibitors may produce nonspecific and undesirable effects. In recent years, genetic approaches targeting HPA have been regarded as a promising alternative.
Compared with adult cancer patients, parents of children with cancer were more likely to be dissatisfied with the informed consent process for participating in clinical trials, according to a study from Dana-Farber/Children's Hospital Cancer Center. The findings will be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Saturday, Oct. 23.
Personal myths, aversive racism, heat and retaliation in baseball, and the power of writing about personal trauma - these are just a few of the research areas of the winners of the 2012 annual awards from the Society for Personality and Social Psychology (SPSP). Each of the recipients has made a unique and significant contribution to understanding the individual and social factors shaping people's personalities, interactions, and behaviors.
Cell Therapeutics, Inc. today announced that it has entered into exchange agreements with certain holders of some of the Company's outstanding 4% Convertible Senior Subordinated Notes due 2010.
› Verified 1 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 1 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 2 |
| Percentage of adult patients getting regular hemodialysis at the center | |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 98 percent of surveyed rheumatologists indicate they will prescribe Roche's Actemra, an interleukin-6 inhibitor, for the treatment of rheumatoid arthritis following the agent's expected launch in 2010.
Previous studies have indicated that the heparanase (HPA) is correlated with histopathological parameters and poor prognosis of gastric cancers. Although their efficiencies in inhibiting the expression of HPA, the traditional HPA inhibitors may produce nonspecific and undesirable effects. In recent years, genetic approaches targeting HPA have been regarded as a promising alternative.
Compared with adult cancer patients, parents of children with cancer were more likely to be dissatisfied with the informed consent process for participating in clinical trials, according to a study from Dana-Farber/Children's Hospital Cancer Center. The findings will be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Saturday, Oct. 23.
Personal myths, aversive racism, heat and retaliation in baseball, and the power of writing about personal trauma - these are just a few of the research areas of the winners of the 2012 annual awards from the Society for Personality and Social Psychology (SPSP). Each of the recipients has made a unique and significant contribution to understanding the individual and social factors shaping people's personalities, interactions, and behaviors.
Cell Therapeutics, Inc. today announced that it has entered into exchange agreements with certain holders of some of the Company's outstanding 4% Convertible Senior Subordinated Notes due 2010.
› Verified 1 days ago
| Adult patients getting regular peritoneal dialysis at the center | 52 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 397 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 94 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 98 percent of surveyed rheumatologists indicate they will prescribe Roche's Actemra, an interleukin-6 inhibitor, for the treatment of rheumatoid arthritis following the agent's expected launch in 2010.
Previous studies have indicated that the heparanase (HPA) is correlated with histopathological parameters and poor prognosis of gastric cancers. Although their efficiencies in inhibiting the expression of HPA, the traditional HPA inhibitors may produce nonspecific and undesirable effects. In recent years, genetic approaches targeting HPA have been regarded as a promising alternative.
Compared with adult cancer patients, parents of children with cancer were more likely to be dissatisfied with the informed consent process for participating in clinical trials, according to a study from Dana-Farber/Children's Hospital Cancer Center. The findings will be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Saturday, Oct. 23.
Personal myths, aversive racism, heat and retaliation in baseball, and the power of writing about personal trauma - these are just a few of the research areas of the winners of the 2012 annual awards from the Society for Personality and Social Psychology (SPSP). Each of the recipients has made a unique and significant contribution to understanding the individual and social factors shaping people's personalities, interactions, and behaviors.
Cell Therapeutics, Inc. today announced that it has entered into exchange agreements with certain holders of some of the Company's outstanding 4% Convertible Senior Subordinated Notes due 2010.
› Verified 1 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC - Nalco Home Program with elevated calcium levels.
| Patients with hypercalcemia | 56 |
| Hypercalcemia patient months | 423 |
| Patients with Serumphosphor | 64 |
| Patients with Serumphosphor less than 3.5 mg/dL | 4 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 25 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 34 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 25 |
| Patients with Serumphosphor greater than 7 mg/dL | 13 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 98 percent of surveyed rheumatologists indicate they will prescribe Roche's Actemra, an interleukin-6 inhibitor, for the treatment of rheumatoid arthritis following the agent's expected launch in 2010.
Previous studies have indicated that the heparanase (HPA) is correlated with histopathological parameters and poor prognosis of gastric cancers. Although their efficiencies in inhibiting the expression of HPA, the traditional HPA inhibitors may produce nonspecific and undesirable effects. In recent years, genetic approaches targeting HPA have been regarded as a promising alternative.
Compared with adult cancer patients, parents of children with cancer were more likely to be dissatisfied with the informed consent process for participating in clinical trials, according to a study from Dana-Farber/Children's Hospital Cancer Center. The findings will be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Saturday, Oct. 23.
Personal myths, aversive racism, heat and retaliation in baseball, and the power of writing about personal trauma - these are just a few of the research areas of the winners of the 2012 annual awards from the Society for Personality and Social Psychology (SPSP). Each of the recipients has made a unique and significant contribution to understanding the individual and social factors shaping people's personalities, interactions, and behaviors.
Cell Therapeutics, Inc. today announced that it has entered into exchange agreements with certain holders of some of the Company's outstanding 4% Convertible Senior Subordinated Notes due 2010.
› Verified 1 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 4 |
| Patient months included in arterial venous fistula and catheter summaries | 13 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 98 percent of surveyed rheumatologists indicate they will prescribe Roche's Actemra, an interleukin-6 inhibitor, for the treatment of rheumatoid arthritis following the agent's expected launch in 2010.
Previous studies have indicated that the heparanase (HPA) is correlated with histopathological parameters and poor prognosis of gastric cancers. Although their efficiencies in inhibiting the expression of HPA, the traditional HPA inhibitors may produce nonspecific and undesirable effects. In recent years, genetic approaches targeting HPA have been regarded as a promising alternative.
Compared with adult cancer patients, parents of children with cancer were more likely to be dissatisfied with the informed consent process for participating in clinical trials, according to a study from Dana-Farber/Children's Hospital Cancer Center. The findings will be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Saturday, Oct. 23.
Personal myths, aversive racism, heat and retaliation in baseball, and the power of writing about personal trauma - these are just a few of the research areas of the winners of the 2012 annual awards from the Society for Personality and Social Psychology (SPSP). Each of the recipients has made a unique and significant contribution to understanding the individual and social factors shaping people's personalities, interactions, and behaviors.
Cell Therapeutics, Inc. today announced that it has entered into exchange agreements with certain holders of some of the Company's outstanding 4% Convertible Senior Subordinated Notes due 2010.
› Verified 1 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 36 |
| Hospitalization Rate in facility | 221.9 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 447.1 |
| Hospitalization Rate: Lower Confidence Limit | 116.3 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 98 percent of surveyed rheumatologists indicate they will prescribe Roche's Actemra, an interleukin-6 inhibitor, for the treatment of rheumatoid arthritis following the agent's expected launch in 2010.
Previous studies have indicated that the heparanase (HPA) is correlated with histopathological parameters and poor prognosis of gastric cancers. Although their efficiencies in inhibiting the expression of HPA, the traditional HPA inhibitors may produce nonspecific and undesirable effects. In recent years, genetic approaches targeting HPA have been regarded as a promising alternative.
Compared with adult cancer patients, parents of children with cancer were more likely to be dissatisfied with the informed consent process for participating in clinical trials, according to a study from Dana-Farber/Children's Hospital Cancer Center. The findings will be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Saturday, Oct. 23.
Personal myths, aversive racism, heat and retaliation in baseball, and the power of writing about personal trauma - these are just a few of the research areas of the winners of the 2012 annual awards from the Society for Personality and Social Psychology (SPSP). Each of the recipients has made a unique and significant contribution to understanding the individual and social factors shaping people's personalities, interactions, and behaviors.
Cell Therapeutics, Inc. today announced that it has entered into exchange agreements with certain holders of some of the Company's outstanding 4% Convertible Senior Subordinated Notes due 2010.
› Verified 1 days ago
The rate of readmission show you whether patients who were being treated regularly at FMC - Nalco Home Program were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 31.3 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 48.4 |
| Readmission Rate: Lower Confidence Limit | 18 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 98 percent of surveyed rheumatologists indicate they will prescribe Roche's Actemra, an interleukin-6 inhibitor, for the treatment of rheumatoid arthritis following the agent's expected launch in 2010.
Previous studies have indicated that the heparanase (HPA) is correlated with histopathological parameters and poor prognosis of gastric cancers. Although their efficiencies in inhibiting the expression of HPA, the traditional HPA inhibitors may produce nonspecific and undesirable effects. In recent years, genetic approaches targeting HPA have been regarded as a promising alternative.
Compared with adult cancer patients, parents of children with cancer were more likely to be dissatisfied with the informed consent process for participating in clinical trials, according to a study from Dana-Farber/Children's Hospital Cancer Center. The findings will be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Saturday, Oct. 23.
Personal myths, aversive racism, heat and retaliation in baseball, and the power of writing about personal trauma - these are just a few of the research areas of the winners of the 2012 annual awards from the Society for Personality and Social Psychology (SPSP). Each of the recipients has made a unique and significant contribution to understanding the individual and social factors shaping people's personalities, interactions, and behaviors.
Cell Therapeutics, Inc. today announced that it has entered into exchange agreements with certain holders of some of the Company's outstanding 4% Convertible Senior Subordinated Notes due 2010.
› Verified 1 days ago